The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

January 1998

Volume 38, Issue 1

Pages i–ii, 1–93

  1. Information for Authors

    1. Top of page
    2. Information for Authors
    3. Editorial
    4. Therapeutic Review
    5. Pharmacokinetics and Pharmacodynamics
    6. Erratum
    7. Pharmacokinetics and Pharmacodynamics
    8. Clinical Trials
    9. Drug Metabolism
    10. Drug Interactions
    1. INFORMATION FOR AUTHORS (pages i–ii)

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04367.x

  2. Editorial

    1. Top of page
    2. Information for Authors
    3. Editorial
    4. Therapeutic Review
    5. Pharmacokinetics and Pharmacodynamics
    6. Erratum
    7. Pharmacokinetics and Pharmacodynamics
    8. Clinical Trials
    9. Drug Metabolism
    10. Drug Interactions
    1. A New Look (page 1)

      Deborah L. Keefe

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04368.x

  3. Therapeutic Review

    1. Top of page
    2. Information for Authors
    3. Editorial
    4. Therapeutic Review
    5. Pharmacokinetics and Pharmacodynamics
    6. Erratum
    7. Pharmacokinetics and Pharmacodynamics
    8. Clinical Trials
    9. Drug Metabolism
    10. Drug Interactions
    1. Fenoldopam: A New Dopamine Agonist for the Treatment of Hypertensive Urgencies and Emergencies (pages 2–13)

      James B. Post IV and William H. Frishman

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04369.x

  4. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Information for Authors
    3. Editorial
    4. Therapeutic Review
    5. Pharmacokinetics and Pharmacodynamics
    6. Erratum
    7. Pharmacokinetics and Pharmacodynamics
    8. Clinical Trials
    9. Drug Metabolism
    10. Drug Interactions
    1. Single-Dose Pharmacokinetics and Pharmacodynamics of Alprazolam in Elderly and Young Subjects (pages 14–21)

      Dr. Gary B. Kaplan, Dr. David J. Greenblatt, Dr. Bruce L. Ehrenberg, Ms. Jill E. Goddard, Mr. Jerold S. Harmatz and Dr. Richard I. Shader

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04370.x

    2. Plasma Nitric Oxide Before and After Smoking Cessation with Nicotine Nasal Spray (pages 22–27)

      Virginia M. Miller, Debra A. Lewis, Kevin S. Rud, Kenneth P. Offord, Ivana T. Croghan and Richard D. Hurt

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04371.x

  5. Erratum

    1. Top of page
    2. Information for Authors
    3. Editorial
    4. Therapeutic Review
    5. Pharmacokinetics and Pharmacodynamics
    6. Erratum
    7. Pharmacokinetics and Pharmacodynamics
    8. Clinical Trials
    9. Drug Metabolism
    10. Drug Interactions
    1. You have free access to this content
      ERRATUM (page 27)

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04372.x

  6. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Information for Authors
    3. Editorial
    4. Therapeutic Review
    5. Pharmacokinetics and Pharmacodynamics
    6. Erratum
    7. Pharmacokinetics and Pharmacodynamics
    8. Clinical Trials
    9. Drug Metabolism
    10. Drug Interactions
    1. The Effects of Renal Impairment on the Pharmacokinetics of Zalcitabine (pages 28–33)

      Dr. Munama Bazunga, Dr. Hieu T. Tran, Dr. Heather Kertland, Dr. Moses S. S. Chow and Dr. Joseph Massarella

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04373.x

    2. A Dose Proportionality Study of Eprosartan in Healthy Male Volunteers (pages 34–39)

      Dr. Martha C. Chapelsky, Dr. David E. Martin, Dr. David M. Tenero, Dr. Bernard E. Ilson, Dr. Steven C. Boike, Mr. Rickey Etheredge and Dr. Diane K. Jorkasky

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04374.x

    3. Pharmacokinetics and Safety of a Novel Recombinant Soluble Human Thrombomodulin, ART-123, in Healthy Male Volunteers (pages 40–44)

      Dr. Mitsuyoshi Nakashima, Dr. Mitsutaka Kanamaru, Dr. Kazuo Umemura and Kazuhisa Tsuruta

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04375.x

    4. A Phase I Double-Blind, Placebo-Controlled, Single Rising Dose Study to Determine the Safety, Tolerability, and Pharmacokinetics of Oral YM934 in Healthy Male Volunteers (pages 45–53)

      Dr. Jacobus Burggraaf, Mr. Rik C. Schoemaker, Dr. Ido J. Terpstra and Dr. Adam F. Cohen

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04376.x

    5. Bioequivalence Assessment of a Single 5 mg/day Testosterone Transdermal System Versus Two 2.5 mg/day Systems in Hypogonadal Men (pages 54–59)

      Dr. Douglas E. Wilson, Dr. A. Wayne Meikle, Dr. Steven C. Boike, Ms. Amanda J. Fairless, Mr. Rickey C. Etheredge and Dr. Diane K. Jorkasky

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04377.x

    6. Multiple-Dose Pharmacokinetics and Pharmacodynamics of OROS and Immediate-Release Amitriptyline Hydrochloride Formulations (pages 60–67)

      Suneel K. Gupta, Jaymin Shah, Diane Guinta and Stephen Hwang

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04378.x

    7. Short-Term Effects of Nicardipine and Propranolol on Ocular and Systemic Hemodynamics in Healthy Japanese Subjects (pages 68–73)

      Dr. Yoko Ishii Yatsuka, Dr. Seiichirou Matsukubo, Dr. Tsutomu Kotegawa, Dr. Koichi Nakamura, Dr. Shigeyuki Nakano and Dr. Kazuo Nakatsuka

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04379.x

  7. Clinical Trials

    1. Top of page
    2. Information for Authors
    3. Editorial
    4. Therapeutic Review
    5. Pharmacokinetics and Pharmacodynamics
    6. Erratum
    7. Pharmacokinetics and Pharmacodynamics
    8. Clinical Trials
    9. Drug Metabolism
    10. Drug Interactions
    1. Comparative Efficacy and Safety of Controlled-Release Morphine Suppositories and Tablets in Cancer Pain (pages 74–81)

      Dr. Najib Babul, Dr. Louise Provencher, Dr. Francis Laberge, Mr. Zoltan Harsanyi and Dr. Dwight Moulin

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04380.x

  8. Drug Metabolism

    1. Top of page
    2. Information for Authors
    3. Editorial
    4. Therapeutic Review
    5. Pharmacokinetics and Pharmacodynamics
    6. Erratum
    7. Pharmacokinetics and Pharmacodynamics
    8. Clinical Trials
    9. Drug Metabolism
    10. Drug Interactions
    1. Use of Chlorzoxazone as an In Vivo Probe of Cytochrome P450 2E1: Choice of Dose and Phenotypic Trait Measure (pages 82–89)

      Dr. Reginald F. Frye, Dr. Adedayo Adedoyin, Ms. Kelly Mauro, Dr. Gary R. Matzke and Dr. Robert A. Branch

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04381.x

  9. Drug Interactions

    1. Top of page
    2. Information for Authors
    3. Editorial
    4. Therapeutic Review
    5. Pharmacokinetics and Pharmacodynamics
    6. Erratum
    7. Pharmacokinetics and Pharmacodynamics
    8. Clinical Trials
    9. Drug Metabolism
    10. Drug Interactions
    1. Levofloxacin Does Not Alter Cyclosporine Disposition (pages 90–93)

      D. R. Doose, S. A. Walker, S. C. Chien, R. R. Williams and R. K. Nayak

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04382.x

SEARCH

SEARCH BY CITATION